Evidence map›Paper›PMID 34762774›Full record

ArticleJournal of the International AIDS Society2021

Characteristics and growth of the genetic HIV transmission network of Mexico City during 2020.

Vanessa Dávila-Conn, Claudia García-Morales, Margarita Matías-Florentino, Eduardo López-Ortiz, Héctor E Paz-Juárez, Ángeles Beristain-Barreda, Miroslava Cárdenas-Sandoval, Daniela Tapia-Trejo, Dulce M López-Sánchez, Manuel Becerril-Rodríguez and 8 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. HIV Transmission Dynamics in Greater Mexico City are Shaped by Dense Spatial Mixing.medRxiv : the preprint server for health sciences · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 2 countries.

Vanessa Dávila-ConnCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Claudia García-MoralesCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Margarita Matías-FlorentinoCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Eduardo López-OrtizCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Héctor E Paz-JuárezCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Ángeles Beristain-BarredaCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Miroslava Cárdenas-SandovalCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Daniela Tapia-TrejoCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Dulce M López-SánchezCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Manuel Becerril-RodríguezCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Pedro García-EsparzaCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.
Israel Macías-GonzálezClínica Especializada Condesa, Mexico City, Mexico.
Patricia Iracheta-HernándezClínica Especializada Condesa, Mexico City, Mexico.
Steven WeaverInstitute for Genomics and Evolutionary Medicine, Temple University, Philadelphia, Pennsylvania, USA.
Joel O WertheimDepartment of Medicine, University of California San Diego, La Jolla, California, USA.
Gustavo Reyes-TeránCoordinating Commission of the National Institutes of Health and High Specialty Hospitals, Mexico City, Mexico.
Andrea González-RodríguezClínica Especializada Condesa, Mexico City, Mexico.
Santiago Ávila-RíosCentre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City, Mexico.ORCID 0000-0003-3371-4248
Hospital de Especialidades · MXTemple University · USUniversity of California San Diego · US

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 1994 to 2026
$78.4M
NCATS NIH HHS UL1 TR001442NIAID NIH HHS P30 AI036214
6 · The paper itself

Abstract

introductionMolecular surveillance systems could provide public health benefits to focus strategies to improve the HIV care continuum. Here, we infer the HIV genetic network of Mexico City in 2020, and identify actively growing clusters that could represent relevant targets for intervention.

methodsAll new diagnoses, referrals from other institutions, as well as persons returning to care, enrolling at the largest HIV clinic in Mexico City were invited to participate in the study. The network was inferred from HIV pol sequences, using pairwise genetic distance methods, with a locally hosted, secure version of the HIV-TRACE tool: Seguro HIV-TRACE. Socio-demographic, clinical and behavioural metadata were overlaid across the network to design focused prevention interventions.

resultsA total of 3168 HIV sequences from unique individuals were included. One thousand and one-hundred and fifty (36%) sequences formed 1361 links within 386 transmission clusters in the network. Cluster size varied from 2 to 14 (63% were dyads). After adjustment for covariates, lower age (adjusted odds ratio [aOR]: 0.37, p<0.001; >34 vs. <24 years), being a man who has sex with men (MSM) (aOR: 2.47, p = 0.004; MSM vs. cisgender women), having higher viral load (aOR: 1.28, p<0.001) and higher CD4+ T cell count (aOR: 1.80, p<0.001; ≥500 vs. <200 cells/mm

conclusionsHIV transmission in Mexico City is strongly driven by young MSM with higher education level and recent infection. Nevertheless, leveraging network inference, we identified actively growing clusters that could be prioritized for focused intervention with demographic and risk characteristics that do not necessarily reflect the ones observed in the overall clustering population. Further studies evaluating different models to predict growing clusters are warranted. Focused interventions will have to consider structural and risk disparities between the MSM and the heterosexual populations.

Indexed as

HIV InfectionsSexual and Gender MinoritiesFemaleGene Regulatory NetworksHomosexuality, MaleHumansMaleMexicogenetic clusteringHIV preventionMexicomolecular epidemiologypublic healthtransmission network

Identifiers

PMID34762774
PMCPMC8583431
OpenAlexW3213032392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.